Experimental Pill Nearly Doubles Survival in Pancreatic Cancer
A late-stage study shows an experimental pill nearly doubles median survival for patients with advanced pancreatic ca...
Determine which funds deliver the best annual risk-adjusted returns and how they stack up. Compare contenders to pick winners.
28,456 articlesA late-stage study shows an experimental pill nearly doubles median survival for patients with advanced pancreatic ca...
Pi Network launches two major Pi App Studio updates to boost persistence and AI-driven planning, even as PI token hit...
Intel and AMD delivered contrasting Q4 results, highlighting divergent paths: Intel grappling with foundry losses ami...
Hims & Hers Health announces a major acquisition of Australian digital health firm Eucalyptus, valued at up to $1.15 ...
A director sold 33,000 Clear Secure shares worth about $1.5 million, sparking questions about the stock's outlook. Th...
Bitcoin, Ethereum, and XRP have tumbled as political shifts sharpen policy debates on crypto. This report breaks down...
Trump Media plans a rapid data feed of Truth Social posts for market participants, a move that could reshape timing i...
ADA sinks to multi-year lows as large holders pull profits and reallocate. Traders weigh whether the rout signals cap...
A simple phone call can drain a family’s savings when scam artists push a fake bail emergency. This guide explains ho...
Bitcoin trades around the $63,000 mark as it confronts stubborn resistance and tests key support levels. Analysts war...
Bitcoin hovers near the $73,000 mark as Hormuz headlines dominate the weekend. This report explains how bitcoin will ...
Bitcoin climbs past key levels as XRP and Ethereum join the rally. Traders are watching U.S. policy signals that coul...